Tower Research Capital LLC (TRC) - NEUROBO PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NEUROBO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,878
+21.7%
12,348
+11.8%
0.00%
Q2 2023$4,828
+120600.0%
11,047
+105.1%
0.00%
Q1 2023$40.0%5,3850.0%0.00%
Q4 2022$4
-99.8%
5,385
+2925.3%
0.00%
Q3 2022$2,0001780.00%
Other shareholders
NEUROBO PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
BNP PARIBAS FINANCIAL MARKETS 38$520,0000.00%
BANK OF AMERICA CORP /DE/ 8$00.00%
WELLS FARGO & COMPANY/MN 3$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 3$00.00%
MORGAN STANLEY 2$00.00%
BlackRock Inc. 707$9,0000.00%
Tower Research Capital LLC (TRC) 178$2,0000.00%
VANGUARD GROUP INC 11,393$156,0000.00%
UBS Group AG 3,765$52,0000.00%
View complete list of NEUROBO PHARMACEUTICALS INC shareholders